The global Lab Automation in Drug Discovery market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The report includes an overview of the development of the Lab Automation in Drug Discovery industry chain, the market status of Hospitals and Private Labs (Automated Liquid Handlers, Automated Plate Handlers), Biotech and Pharma (Automated Liquid Handlers, Automated Plate Handlers), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Lab Automation in Drug Discovery.
Regionally, the report analyzes the Lab Automation in Drug Discovery markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Lab Automation in Drug Discovery market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Lab Automation in Drug Discovery market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Lab Automation in Drug Discovery industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Automated Liquid Handlers, Automated Plate Handlers).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Lab Automation in Drug Discovery market.
Regional Analysis: The report involves examining the Lab Automation in Drug Discovery market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Lab Automation in Drug Discovery market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Lab Automation in Drug Discovery:
Company Analysis: Report covers individual Lab Automation in Drug Discovery manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Lab Automation in Drug Discovery This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Private Labs, Biotech and Pharma).
Technology Analysis: Report covers specific technologies relevant to Lab Automation in Drug Discovery. It assesses the current state, advancements, and potential future developments in Lab Automation in Drug Discovery areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Lab Automation in Drug Discovery market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Lab Automation in Drug Discovery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
Automated Liquid Handlers
Automated Plate Handlers
Robotic Arms
Automated Storage and Retrieval Systems
Others
麻豆原创 segment by Application
Hospitals and Private Labs
Biotech and Pharma
Academics and Research Institutes
Others
Major players covered
Thermo Fisher Scientific
Beckman Coulter (Danaher)
Hudson Robotics
Becton, Dickinson and Company
Agilent Technologies
Siemens Healthineers
Tecan Group Ltd
PerkinElmer
Bio-Rad
Roche
Shimadzu Corporation
Aurora Biomed
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lab Automation in Drug Discovery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lab Automation in Drug Discovery, with price, sales, revenue and global market share of Lab Automation in Drug Discovery from 2019 to 2024.
Chapter 3, the Lab Automation in Drug Discovery competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lab Automation in Drug Discovery breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Lab Automation in Drug Discovery market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lab Automation in Drug Discovery.
Chapter 14 and 15, to describe Lab Automation in Drug Discovery sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Lab Automation in Drug Discovery
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Lab Automation in Drug Discovery Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Automated Liquid Handlers
1.3.3 Automated Plate Handlers
1.3.4 Robotic Arms
1.3.5 Automated Storage and Retrieval Systems
1.3.6 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Lab Automation in Drug Discovery Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Private Labs
1.4.3 Biotech and Pharma
1.4.4 Academics and Research Institutes
1.4.5 Others
1.5 Global Lab Automation in Drug Discovery 麻豆原创 Size & Forecast
1.5.1 Global Lab Automation in Drug Discovery Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Lab Automation in Drug Discovery Sales Quantity (2019-2030)
1.5.3 Global Lab Automation in Drug Discovery Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Lab Automation in Drug Discovery Product and Services
2.1.4 Thermo Fisher Scientific Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Thermo Fisher Scientific Recent Developments/Updates
2.2 Beckman Coulter (Danaher)
2.2.1 Beckman Coulter (Danaher) Details
2.2.2 Beckman Coulter (Danaher) Major Business
2.2.3 Beckman Coulter (Danaher) Lab Automation in Drug Discovery Product and Services
2.2.4 Beckman Coulter (Danaher) Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Beckman Coulter (Danaher) Recent Developments/Updates
2.3 Hudson Robotics
2.3.1 Hudson Robotics Details
2.3.2 Hudson Robotics Major Business
2.3.3 Hudson Robotics Lab Automation in Drug Discovery Product and Services
2.3.4 Hudson Robotics Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Hudson Robotics Recent Developments/Updates
2.4 Becton, Dickinson and Company
2.4.1 Becton, Dickinson and Company Details
2.4.2 Becton, Dickinson and Company Major Business
2.4.3 Becton, Dickinson and Company Lab Automation in Drug Discovery Product and Services
2.4.4 Becton, Dickinson and Company Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Becton, Dickinson and Company Recent Developments/Updates
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies Lab Automation in Drug Discovery Product and Services
2.5.4 Agilent Technologies Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Agilent Technologies Recent Developments/Updates
2.6 Siemens Healthineers
2.6.1 Siemens Healthineers Details
2.6.2 Siemens Healthineers Major Business
2.6.3 Siemens Healthineers Lab Automation in Drug Discovery Product and Services
2.6.4 Siemens Healthineers Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Siemens Healthineers Recent Developments/Updates
2.7 Tecan Group Ltd
2.7.1 Tecan Group Ltd Details
2.7.2 Tecan Group Ltd Major Business
2.7.3 Tecan Group Ltd Lab Automation in Drug Discovery Product and Services
2.7.4 Tecan Group Ltd Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Tecan Group Ltd Recent Developments/Updates
2.8 PerkinElmer
2.8.1 PerkinElmer Details
2.8.2 PerkinElmer Major Business
2.8.3 PerkinElmer Lab Automation in Drug Discovery Product and Services
2.8.4 PerkinElmer Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 PerkinElmer Recent Developments/Updates
2.9 Bio-Rad
2.9.1 Bio-Rad Details
2.9.2 Bio-Rad Major Business
2.9.3 Bio-Rad Lab Automation in Drug Discovery Product and Services
2.9.4 Bio-Rad Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Bio-Rad Recent Developments/Updates
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Lab Automation in Drug Discovery Product and Services
2.10.4 Roche Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Roche Recent Developments/Updates
2.11 Shimadzu Corporation
2.11.1 Shimadzu Corporation Details
2.11.2 Shimadzu Corporation Major Business
2.11.3 Shimadzu Corporation Lab Automation in Drug Discovery Product and Services
2.11.4 Shimadzu Corporation Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Shimadzu Corporation Recent Developments/Updates
2.12 Aurora Biomed
2.12.1 Aurora Biomed Details
2.12.2 Aurora Biomed Major Business
2.12.3 Aurora Biomed Lab Automation in Drug Discovery Product and Services
2.12.4 Aurora Biomed Lab Automation in Drug Discovery Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Aurora Biomed Recent Developments/Updates
3 Competitive Environment: Lab Automation in Drug Discovery by Manufacturer
3.1 Global Lab Automation in Drug Discovery Sales Quantity by Manufacturer (2019-2024)
3.2 Global Lab Automation in Drug Discovery Revenue by Manufacturer (2019-2024)
3.3 Global Lab Automation in Drug Discovery Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Lab Automation in Drug Discovery by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Lab Automation in Drug Discovery Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Lab Automation in Drug Discovery Manufacturer 麻豆原创 Share in 2023
3.5 Lab Automation in Drug Discovery 麻豆原创: Overall Company Footprint Analysis
3.5.1 Lab Automation in Drug Discovery 麻豆原创: Region Footprint
3.5.2 Lab Automation in Drug Discovery 麻豆原创: Company Product Type Footprint
3.5.3 Lab Automation in Drug Discovery 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Lab Automation in Drug Discovery 麻豆原创 Size by Region
4.1.1 Global Lab Automation in Drug Discovery Sales Quantity by Region (2019-2030)
4.1.2 Global Lab Automation in Drug Discovery Consumption Value by Region (2019-2030)
4.1.3 Global Lab Automation in Drug Discovery Average Price by Region (2019-2030)
4.2 North America Lab Automation in Drug Discovery Consumption Value (2019-2030)
4.3 Europe Lab Automation in Drug Discovery Consumption Value (2019-2030)
4.4 Asia-Pacific Lab Automation in Drug Discovery Consumption Value (2019-2030)
4.5 South America Lab Automation in Drug Discovery Consumption Value (2019-2030)
4.6 Middle East and Africa Lab Automation in Drug Discovery Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Lab Automation in Drug Discovery Sales Quantity by Type (2019-2030)
5.2 Global Lab Automation in Drug Discovery Consumption Value by Type (2019-2030)
5.3 Global Lab Automation in Drug Discovery Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Lab Automation in Drug Discovery Sales Quantity by Application (2019-2030)
6.2 Global Lab Automation in Drug Discovery Consumption Value by Application (2019-2030)
6.3 Global Lab Automation in Drug Discovery Average Price by Application (2019-2030)
7 North America
7.1 North America Lab Automation in Drug Discovery Sales Quantity by Type (2019-2030)
7.2 North America Lab Automation in Drug Discovery Sales Quantity by Application (2019-2030)
7.3 North America Lab Automation in Drug Discovery 麻豆原创 Size by Country
7.3.1 North America Lab Automation in Drug Discovery Sales Quantity by Country (2019-2030)
7.3.2 North America Lab Automation in Drug Discovery Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Lab Automation in Drug Discovery Sales Quantity by Type (2019-2030)
8.2 Europe Lab Automation in Drug Discovery Sales Quantity by Application (2019-2030)
8.3 Europe Lab Automation in Drug Discovery 麻豆原创 Size by Country
8.3.1 Europe Lab Automation in Drug Discovery Sales Quantity by Country (2019-2030)
8.3.2 Europe Lab Automation in Drug Discovery Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Lab Automation in Drug Discovery Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Lab Automation in Drug Discovery Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Lab Automation in Drug Discovery 麻豆原创 Size by Region
9.3.1 Asia-Pacific Lab Automation in Drug Discovery Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Lab Automation in Drug Discovery Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Lab Automation in Drug Discovery Sales Quantity by Type (2019-2030)
10.2 South America Lab Automation in Drug Discovery Sales Quantity by Application (2019-2030)
10.3 South America Lab Automation in Drug Discovery 麻豆原创 Size by Country
10.3.1 South America Lab Automation in Drug Discovery Sales Quantity by Country (2019-2030)
10.3.2 South America Lab Automation in Drug Discovery Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Lab Automation in Drug Discovery Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Lab Automation in Drug Discovery Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Lab Automation in Drug Discovery 麻豆原创 Size by Country
11.3.1 Middle East & Africa Lab Automation in Drug Discovery Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Lab Automation in Drug Discovery Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Lab Automation in Drug Discovery 麻豆原创 Drivers
12.2 Lab Automation in Drug Discovery 麻豆原创 Restraints
12.3 Lab Automation in Drug Discovery Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Lab Automation in Drug Discovery and Key Manufacturers
13.2 Manufacturing Costs Percentage of Lab Automation in Drug Discovery
13.3 Lab Automation in Drug Discovery Production Process
13.4 Lab Automation in Drug Discovery Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Lab Automation in Drug Discovery Typical Distributors
14.3 Lab Automation in Drug Discovery Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Thermo Fisher Scientific
Beckman Coulter (Danaher)
Hudson Robotics
Becton, Dickinson and Company
Agilent Technologies
Siemens Healthineers
Tecan Group Ltd
PerkinElmer
Bio-Rad
Roche
Shimadzu Corporation
Aurora Biomed
听
听
*If Applicable.
